Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
220 participants
INTERVENTIONAL
2013-05-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Doulas in Early Pregnancy Management
NCT02165540
Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
NCT05532085
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
NCT00855842
Oxytocin Effectiveness in First Trimester Dilatation and Curettage
NCT06469203
The Vaginal Progesterone and Cerclage
NCT02846909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Doula Arm
Women in the doula arm will have standard procedure protocol with addition of doula support at the time of the procedure.
Doula Arm
Control Group
Women in the control arm will have standard procedure protocol at the time of the procedure.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doula Arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age by sonogram \< 13 6/7 weeks gestation
* Desires pregnancy termination
* Ability to understand the study and give informed consent
* Ability to read and comprehend informed consent document in English
Exclusion Criteria
* Gestational age by sonogram \> 13 6/7 weeks gestation
* Inability to understand the study and give informed consent
* Inability to read and comprehend informed consent document in English
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-2246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.